The in vitro effects of remifentanil and fentanyl on isolated human right atria and saphenous veins

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 17, Issue 4, 2003, Pages 465-469

  Duman, Ates ^a   Sahin, Ayse Saide ^b   Atalik, Kismet Esra ^b   Ögün, Cemile Öztin ^b   Ulusoy, Hasan Basri ^b   Durgut, Kadir ^b   Ökesli, Selmin ^b  

^a SELCUK UNIVERSITY   (Turkey)

^b NONE

Author keywords

Fentanyl; Human atrium; Human saphenous vein; In vitro; Myocardial contractility; Remifentanil

Indexed keywords

FENTANYL; REMIFENTANIL; SEROTONIN;

ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; DRUG EFFECT; ELECTROSTIMULATION; HEART ATRIUM MUSCLE; HEART MUSCLE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; ISOLATED HEART; MUSCLE CONTRACTILITY; PRIORITY JOURNAL; SAPHENOUS VEIN; VASCULAR ENDOTHELIUM; VEIN DILATATION;

EID: 0042858156     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(03)00151-4     Document Type: Article

References (31)

1. Stoelting RK: Opioid agonists and antagonists, in Stoelting RK (ed): Pharmacology and Physiology in Anesthetic Practice. Philadelphia, PA, Lippincott-Raven Publishers, 1999, pp 77-112
2. Murat I, Levron JB, Berg A, Saint-Maurice C: Effects of fentanyl on baroreceptor reflex control of heart rate in newborn infants. Anesthesiology 68:717-722, 1988
3. 2 for coronary artery surgery. Anesthesiology 56:112-118, 1982
4. Freye E: Cardiovascular effects of high dosages of fentanyl, meperidine, and naloxone in dogs. Anesth Analg 53:40-47, 1974
5. Camu F, Royston D: Inpatient experience with remifentanil. Anesth Analg 89:S15-21, 1999
6. Sebel PS, Hoke JF, Westmoreland C, et al: Histamine concentrations and hemodynamic responses after remifentanil. Anesth Analg 80:990-993, 1995
7. James MK, Vuong A, Grizzle MK, et al: Hemodynamic effects of GI 87084B, an ultra-short-acting mu-opioid analgesic, in anesthetized dogs. J Pharmacol Exp Ther 263:84-91, 1992
8. Glass PS, Gan TJ, Howell S: A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg 89:S7-14, 1999
9. Kazmaier S, Hanekop GG, Buhre W, et al: Myocardial consqeuences of remifentanil in patients with coronary artery disease. Br J Anaesth 84:578-583, 2000
10. Elliott P, O'Hare R, Bill KM, et al: Severe cardiovascular depression with remifentanil. Anesth Analg 91:58-61, 2000
11. Strauer BE: Contractile responses to morphine, piratramide, meperidine and fentanyl: A comparative study of effects on the isolated ventricular myocardium. Anesthesiology 37:304-310, 1972
12. Süzer O, Süzer A, Aykac Z, et al: Direct cardiac effects in isolated perfused rat hearts measured at increasing concentration of morphine, alfentanil, fentanyl, ketamine, etomidate, thiopentone, midazolam and propofol. Eur J Anaesth 15:480-485, 1998
13. 2+ transients and contraction in rat ventricular myocytes. Anesthesiology 89:1532-1542, 1998
14. Hanouz JL, Yvon A, Guesne G, et al: The in vitro effects of remifentanil, sufentanil, fentanyl, and alfentanil on isolated human right atria. Anesth Analg 93:543-549, 2001
15. White DA, Reitan JA, Kein ND, et al: Decrease in vascular resistance in the isolated canine hindlimb after graded doses of alfentanil, fentanyl, and sufentanil. Anesth Analg 71:29-34, 1990
16. Kohno K, Takaki M, Ishioka K, et al: Effects of intracoronary fentanyl on left ventricular mechanoenergetics in the excised cross-circulated canine heart. Anesthesiology 86:1350-1358, 1997
17. Motomura S, Kissin I, Aultman DF, et al: Effects of fentanyl and nitrous oxide on contractility of blood-perfused papillary muscle of the dog. Anesth Analg 63:47-50, 1984
18. Goldberg AH, Padget CH: Comparative effects of morphine and fentanyl on isolated heart muscle. Anesth Analg 48:978-982, 1969
19. Lowenstein E, Whiting RB, Bittar DA, et al: Local and neurally mediated effects of morphine on skeletal muscle vascular resistance. J Pharmacol Exp Ther 180:359-367, 1972
20. White DA, Reitan JA, Kein ND, et al: Decrease in vascular resistance in the isolated canine hindlimb after graded doses of alfentanil, fentanyl, and sufentanil. Anesth Analg 71:29-34, 1990
21. Bailey PL, Talmage DE, Stanley TH: Intravenous opioid anesthetics, in Miller RD (ed): Anesthesia. Philadelphia, PA, Churchill Livingstone, 2000, pp 273-376
22. Bovill JG, Boer F: Opioids in cardiac anesthesia, in Kaplan JA (ed): Cardiac Anesthesia. Philadelphia, PA, WB Saunders, 1999, pp 573-609
23. Bowdle TA: Adverse effects of opioid agonists and agonist-antagonists in anesthesia. Drug Saf 19:173-189, 1998
24. Flacke JW, Davis LJ, Flacke WE, et al: Effects of fentanyl and diazepam in dogs deprived of autonomic tone. Anesth Analg 64:1053-1059, 1985
25. Sanford TJ Jr, Smith NT, Dec-Silver H, et al: A comparison of morphine, fentanyl, and sufentanil anesthesia for cardiac surgery: induction, emergence and extubation. Anesth Analg 65:259-266, 1986
26. Arndt JO, Mikat M, Parasher C: Fentanyl's analgesic, respiratory and cardiovascular actions in relation to dose and plasma concentration in unanesthetized dogs. Anesthesiology 61:355-361, 1984
27. De Hert SG: Study on the effects of six intravenous anesthetic agents on regional ventricular function in dogs (thiopental, etomidate, propofol, fentanyl, sufentanil, alfentanil). Acta Anaesthesiol Belg 42: 3-39, 1991
28. Lang E, Kapilla A, Shlugman D, et al: Reduction of isoflurane minimal alveolar concentration by remifentanil. Anesthesiology 85: 721-728, 1996
29. Hogue CW Jr, Bowdle TA, O'Leary C, et al: A multicenter evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatient surgery. Anesth Analg 83:279-285, 1996
30. Jhaveri R, Josi P, Batenhorst R, et al: Dose comparison of remifentanil and alfentanil after loss of consciousness. Anesthesiology 87:253-259, 1997
31. Rosow CE, Moss J, Philbin DM, et al: Histamine release during morphine and fentanyl anesthesia. Anesthesiology 56:93-96, 1982